Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in three investor conferences over the coming weeks.
Global Drug Discovery Services Market OverviewThe global drug discovery services market is set to witness strong expansion, ...
Both a copy of our earnings press release and the press release announcing our planned acquisition of AMI can be found at our company website in the Investor Relations section at latticesemi.com. I ...
Triple-negative breast cancer (TNBC), particularly the luminal androgen receptor (LAR) subtype, presents significant ...
Medically integrated dispensing improves affordability, adherence, and toxicity management via embedded pharmacy teams, ...
Q2 2026 Earnings Call April 29, 2026 8:15 AM EDTCompany ParticipantsBrad Chelton - Vice President of Treasury, ...
DNA/RNA-based next-generation sequencing allows earlier diagnosis of neoplastic bile duct strictures, a prospective multicenter real-time study finds.
The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing (NGS) methods in nonclinical studies to assess the safety risks associated ...
Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Rates improved over ...
Hosted on MSN
From sample to insight with next-gen sequencing
Next-generation sequencing (NGS) is transforming research by delivering rapid, high-quality genetic data through streamlined workflows, automation, and advanced logistics. Eurofins Genomics combines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results